← Open Payments lookup

DEBRA HALL: Open Payments

NPI 1619289485 · OLYMPIA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,331 in 71 payments from 13 companies in 2025. Trend: 2023 $270 · 2024 $727 · 2025 $1,331

Food & beverage: $1,331
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.17$260
ABBVIE INC.17$202
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$162
Otsuka America Pharmaceutical, Inc.7$158
Janssen Pharmaceuticals, Inc5$133
Alkermes, Inc.5$105
E.R. Squibb & Sons, L.L.C.4$101
Vanda Pharmaceuticals Inc.2$51
Braeburn Inc.2$41
Supernus Pharmaceuticals, Inc.2$39

Products named: VRAYLAR, CAPLYTA, AUSTEDO XR, ARISTADA, COBENFY, REXULTI, SPRAVATO, INVEGA SUSTENNA.

Industry payments across WA — which companies pay providers there.